Novartis Closes Morphosys, Affecting Hundreds of Jobs

Swiss pharmaceutical giant Novartis announces closure of recently acquired German biotech firm Morphosys by 2025, impacting 330 jobs and raising questions about pharmaceutical industry consolidation.